Jones JS - Search Results

1

DNA-based molecular cytology for bladder cancer surveillance.

Jones JS. Jones JS. Urology. 2006 Mar;67(3 Suppl 1):35-45; discussion 45-7. doi: 10.1016/j.urology.2006.01.039. Urology. 2006. PMID: 16530074 Review.

2

Saturation prostate biopsy with periprostatic block can be performed in office.

Jones JS, Oder M, Zippe CD. Jones JS, et al. J Urol. 2002 Nov;168(5):2108-10. doi: 10.1016/S0022-5347(05)64307-8. J Urol. 2002. PMID: 12394720

3

Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.

Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR. Skacel M, et al. Among authors: jones js. J Urol. 2003 Jun;169(6):2101-5. doi: 10.1097/01.ju.0000066842.45464.cc. J Urol. 2003. PMID: 12771727

4

Parasagittal biopsies add minimal information in repeat saturation prostate biopsy.

Patel AR, Jones JS, Rabets J, DeOreo G, Zippe CD. Patel AR, et al. Among authors: jones js. Urology. 2004 Jan;63(1):87-9. doi: 10.1016/j.urology.2003.08.040. Urology. 2004. PMID: 14751355

5

Prostate cancer detection with office based saturation biopsy in a repeat biopsy population.

Rabets JC, Jones JS, Patel A, Zippe CD. Rabets JC, et al. Among authors: jones js. J Urol. 2004 Jul;172(1):94-7. doi: 10.1097/01.ju.0000132134.10470.75. J Urol. 2004. PMID: 15201745

6

Sexual function after male radical cystectomy in a sexually active population.

Zippe CD, Raina R, Massanyi EZ, Agarwal A, Jones JS, Ulchaker J, Klein EA. Zippe CD, et al. Among authors: jones js. Urology. 2004 Oct;64(4):682-5; discussion 685-6. doi: 10.1016/j.urology.2004.05.056. Urology. 2004. PMID: 15491700

7

Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.

Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C. Jones JS, et al. J Urol. 2006 Feb;175(2):485-8. doi: 10.1016/S0022-5347(05)00211-9. J Urol. 2006. PMID: 16406977

8

The use of urine-based biomarkers in bladder cancer.

Grossman HB, Blute ML, Dinney CP, Jones JS, Liou LS, Reuter VE, Soloway MS. Grossman HB, et al. Among authors: jones js. Urology. 2006 Mar;67(3 Suppl 1):62-4. doi: 10.1016/j.urology.2006.01.036. Urology. 2006. PMID: 16530080 No abstract available.

9

Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.

Berglund RK, Jones JS, Ulchaker JC, Fergany A, Gill I, Kaouk J, Klein EA. Berglund RK, et al. Among authors: jones js. Urology. 2006 Jun;67(6):1253-6. doi: 10.1016/j.urology.2005.12.003. Epub 2006 May 6. Urology. 2006. PMID: 16678888

10

Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.

Yoder BJ, Skacel M, Hedgepeth R, Babineau D, Ulchaker JC, Liou LS, Brainard JA, Biscotti CV, Jones JS, Tubbs RR. Yoder BJ, et al. Among authors: jones js. Am J Clin Pathol. 2007 Feb;127(2):295-301. doi: 10.1309/ADJL7E810U1H42BJ. Am J Clin Pathol. 2007. PMID: 17210520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

663 results

Search Page

Filters